Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Injections × Thoracic × Clear all

Status

Sponsor Class

Study Type

Interventional 52 Observational 1

Sponsor

Cancer Type

Thoracic 1 Gastrointestinal 1 Classical hematology 1 Breast 1

Conditions

Uncommon Pathological Types of Lung Cancer 1

Interventions

Blood Specimen Collection 33 Surveys and Questionnaires 23 Surgical Procedures, Operative 19 Carboplatin 19 Immunotherapy 16 Drug Therapy 16 pembrolizumab 15 osimertinib 15 Radiotherapy 15 Nivolumab 15 Immune Checkpoint Inhibitors 15 atezolizumab 13 Cisplatin 13 Specimen Handling 12 Observation 12 Gene Expression Profiling 12 Bevacizumab 12 Afatinib 12 Pemetrexed 11 Magnetic Resonance Spectroscopy 11 lorlatinib 10 Immunohistochemistry 10 Biopsy 10 Paclitaxel 9 Erlotinib Hydrochloride 9 alectinib 8 Crizotinib 8 durvalumab 7 Therapeutics 7 Polymerase Chain Reaction 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05023837 2022-01-25

Esporta

Hunan Province Tumor Hospital

Uncommon Pathological Types of Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡